Berkshire Hathaway buying OxyChem for $9.7B — could be Warren Buffett’s last big deal

Berkshire Hathaway is making headlines with its $9.7 billion acquisition of OxyChem, marking Warren Buffett's largest deal since the $11.6 billion purchase of Alleghany Insurance in 2022. This move not only showcases Buffett's continued confidence in strategic investments but also raises questions about whether this could be one of his final major transactions. The acquisition is significant as it reflects Berkshire's ongoing commitment to expanding its portfolio in the chemical sector, potentially leading to increased market influence and profitability.